WallStreetZenWallStreetZen

NASDAQ: PDEX
Pro Dex Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Pro Dex revenue was $61.00M for the trailing 12 months ending Dec 31, 2024, with 140% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $16.8M, up 12.8% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PDEX annual revenue was $53.8M, with 16.8% growth year-over-year.

PDEX past revenue growth

How has PDEX's revenue growth performed historically?

Company
26.45%
Industry
9.74%
Market
20.68%
PDEX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PDEX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PDEX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PDEX revenue history

Current Revenue
$61.0M
Current Earnings
$6.7M
Current Profit Margin
11.1%

Be the first to know when PDEX announces revenue.

PDEX Revenue History By Year

PDEX Yearly RevenuePDEX RevenuePDEX ChangePDEX Revenue Growth
2024-06-30$53.84M$7.76M+16.83%
2023-06-30$46.09M$4.05M+9.62%
2022-06-30$42.04M$4.01M+10.55%
2021-06-30$38.03M$3.20M+9.17%
2020-06-30$34.83M$7.66M+28.20%
2019-06-30$27.17M$4.71M+20.95%
2018-06-30$22.47M$522.00k+2.38%
2017-06-30$21.94M$2.75M+14.35%
2016-06-30$19.19M$5.81M+43.38%
2015-06-30$13.38M$2.57M+23.78%
2014-06-30$10.81M-$1.44M-11.73%
2013-06-30$12.25M-$5.01M-29.02%
2012-06-30$17.26M-$6.80M-28.28%
2011-06-30$24.06M$849.00k+3.66%
2010-06-30$23.21M$2.09M+9.89%
2009-06-30$21.12M-$4.00M-15.94%
2008-06-30$25.13M$3.56M+16.52%
2007-06-30$21.56M$4.50M+26.39%
2006-06-30$17.06M$3.23M+23.33%
2005-06-30$13.83M-$366.00k-2.58%
2004-06-30$14.20M$2.21M+18.43%
2003-06-30$11.99M$1.46M+13.91%
2002-06-30$10.53M-$4.32M-29.09%
2001-06-30$14.84M-$1.55M-9.48%
2000-06-30$16.40M-$1.94M-10.60%
1999-06-30$18.34M-$4.31M-19.01%
1998-06-30$22.65M$3.45M+17.98%
1997-06-30$19.20M-$1.37M-6.68%
1996-06-30$20.57MN/AN/A

1 of 2

Pro Dex Revenue FAQ

What was PDEX's revenue last quarter?

On Invalid Date, Pro Dex (NASDAQ: PDEX) reported Q4 2024 revenue of $16.79 million up 33.4% year over year. In the same quarter last year, Pro Dex's revenue was $12.59 million.

What was Pro Dex's revenue in 2024?

Pro Dex's annual revenue for the twelve months ending Jun 30, 2024 was $53.84 million, a 16.83% increase year over year.

How much does Pro Dex make in a day?

Based on Pro Dex annual revenue for the past five years, PDEX makes an average of $117,717.81 per day.

What was Pro Dex's annual revenue growth in the past year?

As of Q2 2025, Pro Dex's revenue has grown 26.45% year over year. This is 16.71 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 9.74%. Pro Dex's revenue in the past year totaled $61.00 million.

How much does Pro Dex make in a year?

Pro Dex's revenue by year for the past five years is:
  • Pro Dex's revenue for the twelve months ending Jun 30, 2024 was $53.84 million, a 16.83% increase year over year.
  • Pro Dex's annual revenue for Jun 30, 2023 was $46.09 million, a 9.62% increase from 2022.
  • Pro Dex's annual revenue for 2022 was $42.04 million, a 10.55% increase from 2021.
  • Pro Dex's annual revenue for 2021 was $38.03 million, a 9.17% increase from 2020.
  • Pro Dex's annual revenue for 2020 was $34.83 million, a 28.2% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.